The utility of rhesus monkey (Macaca mulatta) and other non-human primate models for preclinical testing of Leishmania candidate vaccines

Live attenuated Leishmania vaccines: a potential strategic alternative

(2008) Ricardo Silvestre et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection againstLeishmania

(2008) Blaise Dondji et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Dynamics of immune granuloma formation in aLeishmania braziliensis-induced self-limiting cutaneous infection in the primateMacaca mulatta

(2008) C Souza-Lemos et al.   JOURNAL OF PATHOLOGY

CD8+ T cell efficacy in vaccination and disease

(2008) Victor Appay et al.   NATURE MEDICINE

Vaccines for leishmaniasis in the fore coming 25 years

(2008) Clarisa B. Palatnik-de-Sousa   VACCINE

Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response

(2007) I. Ramos et al.   VACCINE